The Germany Carrier Screening Market was valued at $209.9 Million in 2023 and projected to reach to $551 Million by 2028, representing a compound annual growth rate of 21.3%. Germany's carrier screening market is positioned for exceptional growth through 2028, driven by heightened awareness of genetic health risks and integration of screening into routine clinical practice.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Germany's carrier screening market reached $209.9 million in 2023 and is projected to grow to $551.0 million by 2028, representing a robust CAGR of 21.3%, significantly outpacing the global average of 19.7%.
Germany's advanced healthcare system, strong regulatory framework, and high insurance coverage rates create an ideal environment for rapid adoption of carrier screening technologies and genetic testing services.
Increasing public awareness of genetic disorders, coupled with growing physician advocacy for preventive genetic testing, is driving demand for carrier screening across German healthcare institutions and fertility clinics.
German laboratories and diagnostic centers are rapidly adopting next-generation sequencing (NGS) and advanced molecular testing platforms, enhancing screening accuracy and expanding test panel capabilities.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | PULMONARY CONDITIONS (Medical Condition) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 19.7% from 2023 to 2028 |
| Largest Segment | SERVICES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 2.2 (2023) |
| Revenue Forecast (Billions) | ~USD 5.4 (2028) |
| Segments Covered | Product & Service, Type, Medical Condition, Technology, End User, Product & 2021-2028 |
6 segment dimensions are covered across the global market.
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| CLINICAL LABORATORIES | 36.3 | 43.4 | 52.2 | 62.8 | 75.7 | 91.2 | 109.9 | 133.7 | 20.7 |
| FERTILITY CLINICS | 14.8 | 17.4 | 20.6 | 24.4 | 28.9 | 34.3 | 40.7 | 48.8 | 18.9 |
| HOSPITALS AND MEDICAL CENTERS | 86 | 104.1 | 127 | 154.8 | 188.8 | 230.3 | 281.1 | 346.1 | 22.2 |
| OTHER END USERS | 7.5 | 8.7 | 10.1 | 11.9 | 13.9 | 16.2 | 19 | 22.4 | 17.2 |
| TOTAL | 144.6 | 173.5 | 209.9 | 253.9 | 307.2 | 372 | 450.6 | 551 | 21.3 |
Germany's carrier screening market was valued at $209.9 million in 2023 and is projected to reach $551.0 million by 2028.
Germany's carrier screening market is expected to grow at a compound annual growth rate (CAGR) of 21.3% from 2023 to 2028.
Growth in Germany's carrier screening market is driven by increasing genetic disorder awareness, advanced diagnostic technologies, supportive reimbursement policies, and strong healthcare infrastructure.
Germany's carrier screening market CAGR of 21.3% significantly exceeds the global CAGR of 19.7%, reflecting stronger regional adoption and market maturity.
Germany's market is characterized by adoption of next-generation sequencing, expanded carrier panels, and precision medicine platforms integrated into clinical diagnostic workflows.
The study involved four major activities in estimating the current size of the Carrier Screening Market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (Doctors, Surgeons, Gynecologist, genetic consultant) and supply sides (Carrier Screening product/service providers and distributors).
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2. Tiers of companies are defined based on their total revenue. As of 2021: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Carrier Screening Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

To know about the assumptions considered for the study, Request for Free Sample Report

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Carrier Screening Market industry.
Carrier screening is a type of genetic testing that is used to determine if a person is a carrier for a specific autosomal recessive disease. Similarly, when it is done before or during pregnancy, it allows to find out the chances of having a child with a genetic disorder. Carrier screening involves testing a sample of blood, saliva, or tissue from the inside of the cheek.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Carrier Screening Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report